Innate immune response gene expression profiles in central nervous system of mice infected with rabies virus

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 34, Issue 6, 2011, Pages 503-512

  Zhao, Pingsen ^a,b   Zhao, Lili ^b,c   Zhang, Tao ^a,b   Qi, Yinglin ^b,c   Wang, Tiecheng ^b   Liu, Kejian ^a   Wang, Hualei ^b   Feng, Hao ^b,c   Jin, Hongli ^b,c   Qin, Chuan ^a   Yang, Songtao ^b   Xia, Xianzhu ^a,b  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

CNS infection; Functional enrichment; Gene profiling; Innate immune response; Rabies virus

Indexed keywords

COMPLEMENT; CYTOKINE; INTERFERON INDUCIBLE TRANSCRIPTION FACTOR; INTERFERON STIMULATED TRANSCRIPTION FACTOR; JANUS KINASE; MESSENGER RNA; STAT PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BRAIN; COMPLEMENT GENE; CONTROLLED STUDY; CYTOKINE GENE; DNA MICROARRAY; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENETIC ANALYSIS; GENOME; IMMUNE RESPONSE GENE; INNATE IMMUNITY; INTERFERON INDUCIBLE TRANSCRIPTION FACTOR GENE; INTERFERON STIMULATED GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN DEGRADATION; RABIES; RABIES VIRUS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; MICE; MICE, INBRED BALB C; RABIES; RABIES VIRUS; SIGNAL TRANSDUCTION; VIRAL LOAD;

MUS; RABIES VIRUS;

EID: 81255161009     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2011.09.003     Document Type: Article

References (55)

1. Ray N.B., Ewalt L.C., Lodmell D.L. Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence. J Virol 1995, 69:764-772.
2. Bourhy H., Sureau P., Tordo N. From rabies to rabies-related viruses. Vet Microbiol 1990, 23:115-128.
3. WHO Expert Consultation on Rabies World Health Organ Tech Rep Ser 2005, 931:1-88. back cover.
4. Zhang Y.Z., Xiong C.L., Xiao D.L., Jiang R.J., Wang Z.X., Zhang L.Z., et al. Human rabies in China. Emerg Infect Dis 2005, 11:1983-1984.
5. Ming P., Yan J., Rayner S., Meng S., Xu G., Tang Q., et al. A history estimate and evolutionary analysis of rabies virus variants in China. J Gen Virol 2010, 91:759-764.
6. Griffin D.E. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 2003, 3:493-502.
7. Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27:370-383.
8. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
9. Warke R.V., Xhaja K., Martin K.J., Fournier M.F., Shaw S.K., Brizuela N., et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 2003, 77:11822-11832.
10. Bordignon J., Probst C.M., Mosimann A.L., Pavoni D.P., Stella V., Buck G.A., et al. Expression profile of interferon stimulated genes in central nervous system of mice infected with dengue virus Type-1. Virology 2008, 377:319-329.
11. Fredericksen B.L., Smith M., Katze M.G., Shi P.Y., Gale M. The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol 2004, 78:7737-7747.
12. Koh W.L., Ng M.L. Molecular mechanisms of West Nile virus pathogenesis in brain cell. Emerg Infect Dis 2005, 11:629-632.
13. Kash J.C., Tumpey T.M., Proll S.C., Carter V., Perwitasari O., Thomas M.J., et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006, 443:578-581.
14. Chakrabarti A.K., Vipat V.C., Mukherjee S., Singh R., Pawar S.D., Mishra A.C. Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses. Virol J 2010, 7:219.
15. Lee G., Han D., Song J.Y., Lee Y.S., Kang K.S., Yoon S. Genomic expression profiling in lymph nodes with lymphoid depletion from porcine circovirus 2-infected pigs. J Gen Virol 2010, 91:2585-2591.
16. Gupta N., Santhosh S.R., Babu J.P., Parida M.M., Rao P.V. Chemokine profiling of Japanese encephalitis virus-infected mouse neuroblastoma cells by microarray and real-time RT-PCR: implication in neuropathogenesis. Virus Res 2010, 147:107-112.
17. Yang Y., Ye J., Yang X., Jiang R., Chen H., Cao S. Japanese encephalitis virus infection induces changes of mRNA profile of mouse spleen and brain. Virol J 2011, 8:80.
18. Gupta N., Rao P.V. Transcriptomic profile of host response in Japanese encephalitis virus infection. Virol J 2011, 8:92.
19. Wang Z.W., Sarmento L., Wang Y., Li X.Q., Dhingra V., Tseggai T., et al. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 2005, 79:12554-12565.
20. Prehaud C., Megret F., Lafage M., Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 2005, 79:12893-12904.
21. Yan X., Prosniak M., Curtis M.T., Weiss M.L., Faber M., Dietzschold B., et al. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J Neurovirol 2001, 7:518-527.
22. Wong M.L., Medrano J.F. Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85.
23. Deng H.K., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997, 388:296-300.
24. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
25. Huber W., von Heydebreck A., Sultmann H., Poustka A., Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002, 18(Suppl. 1):S96-S104.
26. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. Article 3.
27. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13.
28. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
29. Beutler B., Eidenschenk C., Crozat K., Imler J.L., Takeuchi O., Hoffmann J.A., et al. Genetic analysis of resistance to viral infection. Nat Rev Immunol 2007, 7:753-766.
30. Takeuchi O., Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008, 20:17-22.
31. Vaidya S.A., Cheng G. Toll-like receptors and innate antiviral responses. Curr Opin Immunol 2003, 15:402-407.
32. Rieder M., Conzelmann K.K. Rhabdovirus evasion of the interferon system. J Interferon Cytokine Res 2009, 29:499-509.
33. Ito N., Moseley G.W., Blondel D., Shimizu K., Rowe C.L., Ito Y., et al. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J Virol 2010, 84:6699-6710.
34. Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Sawaki Y., et al. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol 2010, 84:4002-4012.
35. Rieder M., Brzozka K., Pfaller C.K., Cox J.H., Stitz L., Conzelmann K.K. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol 2011, 85:842-852.
36. Vidy A., Chelbi-Alix M., Blondel D. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol 2005, 79:14411-14420.
37. Vidy A., El Bougrini J., Chelbi-Alix M.K., Blondel D. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 2007, 81:4255-4263.
38. Chelbi-Alix M.K., Vidy A., El Bougrini J., Blondel D. Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, STAT1, and PML nuclear bodies. J Interferon Cytokine Res 2006, 26:271-280.
39. Lafon M., Megret F., Meuth S.G., Simon O., Velandia Romero M.L., Lafage M., et al. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J Immunol 2008, 180:7506-7515.
40. Chopy D., Pothlichet J., Lafage M., Megret F., Fiette L., Si-Tahar M., et al. Ambivalent role of the innate immune response in rabies virus pathogenesis. J Virol 2011, 85:6657-6668.
41. Bourne N., Scholle F., Silva M.C., Rossi S.L., Dewsbury N., Judy B., et al. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol 2007, 81:9100-9108.
42. Johnston C., Jiang W., Chu T., Levine B. Identification of genes involved in the host response to neurovirulent alphavirus infection. J Virol 2001, 75:10431-10445.
43. Bigger C.B., Guerra B., Brasky K.M., Hubbard G., Beard M.R., Luxon B.A., et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004, 78:13779-13792.
44. Sariol C.A., Munoz-Jordan J.L., Abel K., Rosado L.C., Pantoja P., Giavedoni L., et al. Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin Vaccine Immunol 2007, 14:756-766.
45. Knapp S., Yee L.J., Frodsham A.J., Hennig B.J., Hellier S., Zhang L., et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 2003, 4:411-419.
46. Kajaste-Rudnitski A., Mashimo T., Frenkiel M.P., Guenet J.L., Lucas M., Despres P. The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J Biol Chem 2006, 281:4624-4637.
47. Warke R.V., Martin K.J., Giaya K., Shaw S.K., Rothman A.L., Bosch I. TRAIL is a novel antiviral protein against dengue virus. J Virol 2008, 82:555-564.
48. Tumpey T.M., Szretter K.J., Van Hoeven N., Katz J.M., Kochs G., Haller O., et al. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 2007, 81:10818-10821.
49. Yuan W., Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 2001, 20:362-371.
50. Ritchie K.J., Hahn C.S., Kim K.I., Yan M., Rosario D., Li L., et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 2004, 10:1374-1378.
51. Lenschow D.J., Giannakopoulos N.V., Gunn L.J., Johnston C., O'Guin A.K., Schmidt R.E., et al. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 2005, 79:13974-13983.
52. Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J., Jacobs B.S., et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 2005, 336:496-506.
53. Lu G., Reinert J.T., Pitha-Rowe I., Okumura A., Kellum M., Knobeloch K.P., et al. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 2006, 52:29-41.
54. Chen L., Sun J., Meng L., Heathcote J., Edwards A.M., McGilvray I.D. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. J Gen Virol 2010, 91:382-388.
55. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004, 10:1366-1373.